Diltiazem Hydrochloride Extended-Release Capsules, USP

PRODUCT DETAILS

  • RLD: DILACOR XR®
  • Strength: Available in 120 mg,
    180 mg, and 240 mg Capsules
  • Therapeutic Class: Cardiovascular Agent

StrengthNDC NumberSaleable UnitWholesaler Numbers
120 mg70436-191-01Bottle of 100Cardinal Health: 5806823
McKesson: 2642023
Amerisource: 10272228
180 mg70436-192-01Bottle of 100Cardinal Health: 5806849
McKesson: 2642049
Amerisource: 10272227
240 mg70436-193-01Bottle of 100Cardinal Health: 5806864
McKesson: 2642064
Amerisource: 10272233

Diltiazem Hydrochloride Extended-Release Capsules, USP are supplied as follows:

120 mg, opaque yellow cap and white body, imprinted with “A” and “148” on the cap in black ink.

180 mg, opaque light orange cap and white body, imprinted with “A” and “149” on the cap in black ink.

240 mg, opaque chocolate brown cap and white body, imprinted with “A” on the cap and “150” on the body in black ink.

Store at 20° to 25°C (68° to 77°F); excursions permitted to 15° to 30°C (59° to 86°F). [See USP Controlled Room Temperature].

We have been made aware of recent scams that offer false employment opportunities or request financial commitments purportedly on behalf of Slate Run Pharmaceuticals. Unsuspecting job seekers have reported receiving unsolicited contacts such as e-mails and phone calls which may request personal information or offers of employment. Please note that these communications are fraudulent and are not affiliated with Slate Run Pharmaceuticals. Slate Run Pharmaceuticals never requires a financial deposit for employment consideration nor do we offer unsolicited employment packages.

You can reach out to Slate Run Pharmaceuticals at http://www.slaterunpharma.com/get-in-touch/. If you receive a suspicious proposal, please contact your local law enforcement agency for guidance.